Evidence map›Paper›PMID 37471420›Full record

ReviewAmerican journal of physiology. Renal physiology2023

The unique structural and functional characteristics of glomerular endothelial cell fenestrations and their potential as a therapeutic target in kidney disease.

Natalie C Finch, Chris R Neal, Gavin I Welsh, Rebecca R Foster, Simon C Satchell

Abstract readReview
In one paragraph

Review in American journal of physiology. Renal physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Targeting renal tubular epithelial cellsActa pharmaceutica Sinica. B · 2025
    Article
  6. SUL-138 mitigates accelerated endothelial aging and protects the kidney.Clinical science (London, England : 1979) · 2025
    Article
  7. Review
  8. Protease domain exosites regulate extravascular binding of factor IX(a).Journal of thrombosis and haemostasis : JTH · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Terpenes in the management of chronic kidney disease.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  18. Review
  19. Review
  20. Non-voltage-gated CaAmerican journal of physiology. Renal physiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalie C FinchBristol Renal, University of Bristol, United Kingdom.ORCID 0000-0002-3203-7276
Chris R NealBristol Renal, University of Bristol, United Kingdom.
Gavin I WelshBristol Renal, University of Bristol, United Kingdom.ORCID 0000-0002-2148-6658
Rebecca R FosterBristol Renal, University of Bristol, United Kingdom.ORCID 0000-0002-9645-1476
Simon C SatchellBristol Renal, University of Bristol, United Kingdom.ORCID 0000-0001-5276-4537

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glomerular endothelial cell (GEnC) fenestrations are a critical component of the glomerular filtration barrier. Their unique nondiaphragmed structure is key to their function in glomerular hydraulic permeability, and their aberration in disease can contribute to loss of glomerular filtration function. This review provides a comprehensive update of current understanding of the regulation and biogenesis of fenestrae. We consider diseases in which GEnC fenestration loss is recognized or may play a role and discuss methods with potential to facilitate the study of these critical structures. Literature is drawn from GEnCs as well as other fenestrated cell types such as liver sinusoidal endothelial cells that most closely parallel GEnCs.

Indexed as

Endothelial CellsKidney DiseasesEndotheliumGlomerular Filtration BarrierHumansKidney Glomerulusendothelialfenestrationsfiltrationfunctionglomerular

Identifiers

PMID37471420
PMCPMC10639027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.